(Q80579624)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

Eny Maria Goloni-Bertollo

1 January 2020

author

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

José Roberto Lopes Ferraz Filho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marcos Pontes Munis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Antonio Soares Souza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rafael Angelo Sanches

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Erika Cristina Pavarino-Bertelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

30 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

305-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18231788%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00247-007-0712-x

1 January 2020

exact match

0 references

cites work

Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.

1 reference

12 December 2020

1 reference

12 December 2020

Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children

1 reference

12 December 2020

Characteristics of Lisch Nodules in Patients With Neurofibromatosis Type 1

1 reference

12 December 2020

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain

1 reference

12 December 2020

Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients

1 reference

12 December 2020

The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

1 reference

12 December 2020

Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

1 reference

12 December 2020

[Neurofibromatosis type 1 or Von Recklinghausen's disease]

1 reference

12 December 2020

Pediatric brain MRI in neurofibromatosis type I.

1 reference

12 December 2020

Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

1 reference

12 December 2020

Neuroimaging findings in neurofibromatosis type 1 and 2.

1 reference

12 December 2020

Neurofibromatosis 1: clinical review and exceptions to the rules

1 reference

12 December 2020

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference

1 reference

12 December 2020

Incidental findings on pediatric MR images of the brain.

1 reference

12 December 2020

Orbit deformities in craniofacial neurofibromatosis type 1.

1 reference

12 December 2020

Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities

1 reference

12 December 2020

Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

1 reference

12 December 2020

Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.

1 reference

12 December 2020

MRI findings in children with neurofibromatosis type 1: a prospective study.

1 reference

12 December 2020

Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children

1 reference

12 December 2020

Analysis of neurofibromatosis 1 (NF1) lesions by body segment

1 reference

12 December 2020

Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T.

1 reference

12 December 2020

Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?

1 reference

12 December 2020

High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis

1 reference

12 December 2020

MR imaging of optic pathways in patients with neurofibromatosis

1 reference

12 December 2020

Genetics of neurofibromatosis 1 and the NF1 gene

1 reference

12 December 2020

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

1 reference

12 December 2020

Atypical focal non-neoplastic brain changes in neurofibromatosis type 1: mass effect and contrast enhancement

1 reference

12 December 2020

MR imaging of the developing human brain. Part 2. Postnatal development

1 reference

12 December 2020

Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1

1 reference

12 December 2020

Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.

1 reference

12 December 2020